157 related articles for article (PubMed ID: 19205286)
1. Effects of Clara cell 10 (CC10) protein on symptoms and signs of allergic rhinitis.
Widegren H; Andersson M; Greiff L
Ann Allergy Asthma Immunol; 2009 Jan; 102(1):51-6. PubMed ID: 19205286
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
[TBL] [Abstract][Full Text] [Related]
4. Effects of topical formoterol alone and in combination with budesonide in a pollen season model of allergic rhinitis.
Ahlström Emanuelsson C; Andersson M; Persson CG; Thorsson L; Greiff L
Respir Med; 2007 Jun; 101(6):1106-12. PubMed ID: 17215115
[TBL] [Abstract][Full Text] [Related]
5. Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis.
Andersson M; Greiff L; Wollmer P
Acta Otolaryngol; 2008 Jun; 128(6):666-9. PubMed ID: 18568502
[TBL] [Abstract][Full Text] [Related]
6. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
[TBL] [Abstract][Full Text] [Related]
7. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
[TBL] [Abstract][Full Text] [Related]
8. Effects of TNFalpha on the human nasal mucosa in vivo.
Widegren H; Korsgren M; Andersson M; Greiff L
Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
[TBL] [Abstract][Full Text] [Related]
9. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
Greiff L; Persson CG; Andersson M
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model.
Andersson M; Svensson C; Persson C; Akerlund A; Greiff L
Ann Allergy Asthma Immunol; 2000 Oct; 85(4):279-83. PubMed ID: 11061470
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
[TBL] [Abstract][Full Text] [Related]
12. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
Kurowski M; Kuna P; Górski P
Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
[TBL] [Abstract][Full Text] [Related]
13. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.
Baroody FM; Shenaq D; DeTineo M; Wang J; Naclerio RM
J Allergy Clin Immunol; 2009 Jun; 123(6):1342-8. PubMed ID: 19428097
[TBL] [Abstract][Full Text] [Related]
14. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
[TBL] [Abstract][Full Text] [Related]
16. Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber.
Stuebner P; Horak F; Zieglmayer R; Arnáiz E; Leuratti C; Pérez I; Izquierdo I
Ann Allergy Asthma Immunol; 2006 Jan; 96(1):37-44. PubMed ID: 16440531
[TBL] [Abstract][Full Text] [Related]
17. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis.
Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M
J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796
[TBL] [Abstract][Full Text] [Related]
18. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
[TBL] [Abstract][Full Text] [Related]
19. Effects of butterbur treatment in intermittent allergic rhinitis: a placebo-controlled evaluation.
Gray RD; Haggart K; Lee DK; Cull S; Lipworth BJ
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):56-60. PubMed ID: 15281472
[TBL] [Abstract][Full Text] [Related]
20. Low levels of CC16 in nasal fluid of children with birch pollen-induced rhinitis.
Johansson S; Keen C; Ståhl A; Wennergren G; Benson M
Allergy; 2005 May; 60(5):638-42. PubMed ID: 15813809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]